Metformin Anti-Tumor Effect via Disruption of the MID1 Translational Regulator Complex and AR Downregulation in Prostate Cancer Cells

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction: The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering With the MID1 Complex

PLoS ONE
Multidisciplinary
2014English

Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells

OncoTargets and Therapy
OncologyPharmacology
2020English

Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity

PLoS ONE
Multidisciplinary
2013English

Downregulation of microRNA-574 in Cancer Stem Cells Causes Recurrence of Prostate Cancer via Targeting REL

Oncology Reports
MedicineCancer ResearchOncology
2016English

Metformin Increases Chemo-Sensitivity via Gene Downregulation Encoding DNA Replication Proteins in 5-Fu Resistant Colorectal Cancer Cells

Oncotarget
Oncology
2017English

Antitumor Effect of Sunitinib in Human Prostate Cancer Cells Functions via Autophagy

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

PMA Induces Androgen Receptor Downregulation and Cellular Apoptosis in Prostate Cancer Cells

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2014English

Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2014English

A Novel Anti-Cancer Effect of Resveratrol: Reversal of Epithelial-Mesenchymal Transition in Prostate Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy